Publication Name	World Journal of Immunology
Manuscript ID	62657
Country	Spain

Received	2021-01-14 09:10
Peer-Review Started	2021-01-14 09:12
To Make the First Decision
Return for Revision	2021-02-15 03:49
Revised	2021-02-24 11:41
Second Decision	2021-06-07 12:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-06-07 13:23
Articles in Press	2021-06-07 13:23
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-07-02 07:50
Typeset the Manuscript	2021-07-22 07:42
Publish the Manuscript Online	2021-07-22 09:09

ISSN	2219-2824 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Minireviews
Article Title	New era of personalized medicine: Advanced therapy medicinal products in Europe
Manuscript Source	Unsolicited Manuscript
All Author List	Javier García-González, Sonia Marhuenda-Castillo, Sheila Romero-Carretero and Jesús Beltrán-García
Funding Agency and Grant Number
Corresponding Author	Jesús Beltrán-García, PhD, Academic Research, Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, Av. de Blasco Ibáñez, 15, Valencia 46010, Spain. jesus.beltran@ext.uv.es
Key Words	Advanced therapy; Advanced therapy medicinal products; Cell therapy; Gene therapy; Tissue therapy; Chimeric antigen receptor T cell
Core Tip	The advanced therapy medicinal products (ATMPs) have opened a new world of possibilities in the prevention and treatment of a large number of diseases that have not been effectively treated to date. ATMPs are based on the use of novel and sophisticated technologies adapted to each patient (personalized medicine), as well as on the discovery of novel and reliable biomarkers for the prediction and monitoring of clinical response. In this work we describe the latest advances in ATMPs approved by the European Medicines Agency, the molecular mechanisms that guided their medical benefits, how they work, the current status, and how they can change the medicine field forever, approaching precision personalized medicine.
Publish Date	2021-07-22 09:09
Citation	García-González J, Marhuenda-Castillo S, Romero-Carretero S, Beltrán-García J. New era of personalized medicine: Advanced therapy medicinal products in Europe. World J Immunol 2021; 11(1): 1-10
URL	https://www.wjgnet.com/2219-2824/full/v11/i1/1.htm
DOI	https://dx.doi.org/10.5411/wji.v11.i1.1

Full Article (PDF)	WJI-11-1.pdf
Full Article (Word)	WJI-11-1.docx
Manuscript File	62657_Auto_Edited-ZMG-Webster J - Beltran-Garcia J[23197]-Clear.docx
Answering Reviewers	62657-Answering reviewers.pdf
Audio Core Tip	62657-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	62657-Conflict-of-interest statement.pdf
Copyright License Agreement	62657-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	62657-Language certificate.pdf
Peer-review Report	62657-Peer-review(s).pdf
Scientific Misconduct Check	62657-Bing-Wang JL-1.jpg
Scientific Misconduct Check	62657-Scientific misconduct check.pdf
Scientific Editor Work List	62657-Scientific editor work list.pdf